PHARMA-BIO SERV, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
PHARMA-BIO SERV, INC. (PBSV) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.68 per share for the 12-month period ending 2015-10-31, per its 10-K filed 2016-01-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2016-01-29
- PHARMA-BIO SERV, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2015 was $0.68, a 40.02% increase from fiscal 2014.
- PHARMA-BIO SERV, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2014 was $0.48.
- PHARMA-BIO SERV, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was $0.00.
- PHARMA-BIO SERV, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2012 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2015-10-31 | $0.68 10-K · filed 2016-01-29 |
| 2014-10-31 | $0.48 10-K · filed 2016-01-29 |
| 2013-10-31 | $0.00 10-K · filed 2014-01-29 |
| 2012-10-31 | $0.00 10-K · filed 2014-01-29 |